Lara, Primo N. Jr.
Mayerson, Edward
Gertz, Erik
Tangen, Catherine
Goldkorn, Amir
van Loan, Marta
Hussain, Maha http://orcid.org/0000-0003-0380-9465
Gupta, Shilpa
Zhang, Jingsong http://orcid.org/0000-0003-1192-5116
Parikh, Mamta
Twardowski, Przemyslaw
Quinn, David I.
LeBlanc, Michael
Thompson, Ian
Agarwal, Neeraj http://orcid.org/0000-0003-1076-0428
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA180888, CA180819, CA093373)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Takeda Pharmaceuticals U.S.A.
Jerry and Susan Knapp
Article History
Received: 18 October 2023
Revised: 12 February 2024
Accepted: 16 February 2024
First Online: 29 February 2024
Competing interests
: The authors declare no competing interests.